Dr. Kelley is a faculty member in the Division of Infectious Diseases with a multi-disciplinary background and previous experience in clinical HIV medicine, HIV epidemiology and clinical outcomes research, and laboratory based HIV research. The current focus of her research is on translational immunology studies of HIV susceptibility in sexual and gender minorities with a particular interest in biomedical prevention interventions. The goal of her research is to work towards optimizing efficacy of HIV biomedical prevention interventions, such as an HIV vaccine, pre- and post-exposure prophylaxis, and microbicides, for populations at high risk of infection. She is currently principal investigator of several ongoing studies examining the real-life, human, sexual contexts that influence the rectal mucosal immune environment in men who have sex with men and transgender women. Dr. Kelley also services as Associate Director of the Emory CFAR Clinical Core and as an investigator for the HVTN and the HPTN at the Hope Clinic.